ARTICLE | Company News
Fina BioSolutions, China National Pharmaceutical Group Corp. deal
August 27, 2012 7:00 AM UTC
Fina granted the Chengdu Institute of Biological Products Co. Ltd. rights in China to use Fina's conjugate vaccine technology to develop and commercialize pneumococcal vaccines. Fina is eligible for u...